GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS
CAUTION: Investigational device. Limited by United States law to investigational use.
Apr 12, 2022
First Patient Enrolled in Investigational Study of the GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System
Investigating the safety and effectiveness of a stent graft system designed to provide endovascular aneurysm repair (EVAR) with angulation control to patients previously considered untreatable
Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>®</sup>
Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts
GORE® Molding & Occlusion Balloon for Endovascular Aortic Repair Receives Approval in the United States, Japan, and Europe
New balloon that addresses EVAR stent graft seal and temporary vessel occlusion challenges
Gore Announces Successful Patient Implant of Endovascular Stent Graft for the Ascending Aorta
GORE® Ascending Stent Graft, an investigational device, is an off-the-shelf endovascular solution designed to treat life-threatening Type A dissections of the ascending aorta
Gore Acquires Pipeline Medical Technologies, Inc.
Acquisition of transcatheter mitral chordal repair technology builds on Gore’s structural heart capabilities
First Patient in Europe Receives Implant of GORE® EXCLUDER® Conformable AAA Endoprosthesis with ACTIVE CONTROL System and Enrolls in Post-Market Registry
Investigator initiated EXCeL Registry will assess safety and abdominal aortic aneurysm treatment success in patients with challenging anatomies